Transpact Enterprises share price
BSE: 542765Healthcare Equipment & SuppliesSmall Cap
Last close ₹99.16up ₹4.72 (5.00%)
Share price at the BSE close on 19 Oct 2026. Previous close ₹94.44.
52-week range of traded prices to 19 Oct 2026
₹81.47Low, 1 Sep 2026₹236.10High, 21 Oct 2025
- Under BSE's graded surveillance, stage 0, and long-term additional surveillance, stage I, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3.83 Cr4,863rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 May 2026
- 44.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 7.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 May 2026
- 17.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.11
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,500
Results
Standalone; ₹ crore, the charts by years to March, the table by half year.Half-yearly results
Half year to Mar 2026, against the half year beforeFiled 30 May
- RevenueRevenue. The pill is the change in revenue against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.09 Crdown 10.53%
- Net profitNet profit. The pill is the change in net profit against the half year before: this period's figure divided by that one's, less one, in per cent.
- ₹0.04 Crdown 25.10%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 43.5%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 5 of the 7 years shown
The years either side of a change of basis do not compare. From the year to Mar 2023, the company reports a discontinued business.
| ₹ crore | Sep 2022Filed 2 Nov | Sep 2023Filed 24 Jan | Mar 2024Filed 5 Jul | Mar 2025Filed 13 Jun | Sep 2025Filed 15 Nov | Mar 2026Filed 30 May |
|---|---|---|---|---|---|---|
| Revenue | 0.38 | 0.00 | 0.00 | 0.08 | 0.10 | 0.09 |
| Net profit | 0.02 | −0.05 | −0.06 | 0.05 | 0.05 | 0.04 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 6.2% | – | – | 61.6% | 52.0% | 43.5% |
Standalone. The last eight half years, but for those filed as quarters, which are below. The latest is shaded.
| ₹ crore | Mar 2023Filed 30 May | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024Filed 14 Nov |
|---|---|---|---|---|---|---|---|
| Revenue | 0.38 | – | – | – | – | – | 0.00 |
| Net profit | −0.07 | – | – | – | – | – | −0.05 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −17.2% | – | – | – | – | – | – |
Standalone. The quarters the company also filed in the same span. No results on record for the quarters to Jun 2023, Sep 2023, Dec 2023, Mar 2024 and Jun 2024.
Business segments
In the year to Mar 2026 the company reports one business segment, Financial services, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +6.5% | +860.0% | −88.9% | 0.0% |
| 3 years | +29.6% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 and 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Peers and competitors
Medical Equipment & Supplies, 27 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Transpact Enterprises in market cap. Transpact Enterprises's own figures are from its last trade, on 19 Oct 2026. 1 company in the table last traded before then: its row is priced on its last trade.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Choksi AsiaCHOKSI | 113 | 21.8 | 2.7 | 16.0 | +21.4% | – | 13.1% | 14.7% | 0.00% |
 Shree PacetronixSHREEPAC | 59 | 18.3 | 3.3 | 11.5 | +22.5% | +210.4% | 20.3% | 21.8% | 0.00% |
 Mohini Health & HygieneMHHL | 52 | – | 0.6 | – | −13.9% | −382.3% | −17.2% | – | 0.00% |
 Amkay ProductsAMKAY | 46 | 20.0 | 1.8 | – | +9.5% | −30.8% | 9.2% | – | 0.00% |
 Royal SenseROYAL | 37 | 5.2 | 0.9 | – | +67.5% | +13.0% | 21.0% | – | 0.00% |
 GKB OphthalmicsGKB | 30 | 9.3 | 0.6 | 3.6 | +29.9% | – | 6.2% | 10.5% | 0.00% |
 Galaxy MedicareGML | 27 | 8.0 | 0.7 | – | – | – | 8.5% | – | 3.88% |
 Centenial Surgical SutureCSURGSU | 25 | – | 0.9 | 5.8 | +6.7% | – | −4.8% | 5.3% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
Transpact Enterprises share price by year
Each calendar year to 2025.Transpact Enterprises share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 137.90 | −33.6% | 297.50 | 120.00 |
| 2024 | 207.60 | −46.1% | 483.80 | 149.00 |
| 2023 | 385.00 | +150.8% | 385.00 | 95.00 |
| 2022 | 153.50 | −0.3% | 175.00 | 130.00 |
| 2021 | 154.00 | +18.5% | 176.50 | 129.00 |
| 2020 | 130.00 | −1.5% | 136.00 | 130.00 |
| 2019 | 132.00 | – | 136.00 | 130.50 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2022 is from its first session, 31 Jan 2022. 2020 is from its first session, 31 Jan 2020. 2019 is from its first session, 5 Sep 2019. The close is the year's last trade for 2021 (18 Nov 2021), 2020 (3 Nov 2020) and 2019 (19 Nov 2019).
Recent sessions
The last 10 trading days to 19 Oct 2026, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 19 Oct 2026 | 99.16 | 99.16 | 99.16 | 99.16 | 99.16 | 2,500 |
| 12 Oct 2026 | 94.44 | 94.44 | 94.44 | 94.44 | 94.44 | 1,000 |
| 8 Oct 2026 | 90.07 | 90.07 | 89.95 | 89.95 | 90.03 | 1,500 |
| 7 Oct 2026 | 85.79 | 85.79 | 85.79 | 85.79 | 85.79 | 17,000 |
| 22 Sep 2026 | 90.30 | 90.30 | 90.30 | 90.30 | 90.30 | 1,000 |
| 1 Sep 2026 | 81.47 | 86.00 | 81.47 | 86.00 | 83.73 | 1,000 |
| 24 Aug 2026 | 85.75 | 85.75 | 85.75 | 85.75 | 85.75 | 500 |
| 21 Aug 2026 | 90.25 | 90.25 | 90.25 | 90.25 | 90.25 | 500 |
| 18 Aug 2026 | 95.50 | 95.50 | 95.00 | 95.00 | 95.20 | 2,000 |
| 17 Aug 2026 | 95.00 | 99.00 | 95.00 | 99.00 | 96.00 | 2,000 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Transpact Enterprises Limited
- BSE code
- 542765
- ISIN
- INE06YD01010
- Industry
- Healthcare Equipment & Supplies
- Listed
- Sep 2019
- Face value
- ₹10
- CIN
- U66110MH2013PLC243247
- Corporate identity number, the registrar of companies' code for it